Cancer and Precision Medicine
Cancer is a disease derived from genetic variation. In the process of cancerization into malignant cells, all normal cells produce genetic mutations, which in turn affect the abnormal expression of the protein of the gene, and gradually develop a series of tumor characteristics, which eventually lead to cancer.
Precision medicine is to focus on biomarkers related to tumor characteristics. Through a new generation of detection methods, we can understand the heterogeneity of tumors and tailor the most suitable treatment strategies according to the individual differences of each patient.
How to find out the best treatment strategy?
How to best interpret your tumor characteristics and assist clinicians to develop the best treatment strategy for you?
Gene mutation analysis
Gene mutation + Protein expression analysis
With available Treatment options
Without available Treatment options
Study showed that only 27% of patients have one or more treatment options available based on gene mutation test results. With tumor protein expression analysis, overall treatment option benefit is increased to 92%. Synchronized analysis of gene mutation and protein expression allows a more comprehensive interpretation of tumor characteristics, providing the most relevant medication information and guiding clinicians in their treatment decision making.
Is conventional Cancer Genetic Testing sufficient?
Advantages of OncoDNA New Generation Cancer Genetic Testing
1 Dual analysis: tissue and blood samples
A Combined analysis of tissue biopsy and blood sample within one testing, providing more comprehensive information regarding tumor molecular profiling
A combined analysis of five prediction biomarkers, providing the most complete prediction on immunotherapy outcomes
CD8 expression analysis
Tumor mutational burden (TMB) analysis
PD-L1 expression analysis
Microsatellite instability (MSI) analysis
Specific mutation hotspots (MUT) analysis
3 Customized analysis : blood monitoring
Real-time adjustment for the most appropriate treatment option
OncoDNA New Generation Cancer Genetic Testing
When to use OncoDNA New Generation Cancer Genetic Testing?
When the cancer is diagnosed
What kind of treatment is the best for me?
Assists the clinicians in selecting the most appropriate medication
What if the front-line treatment does not provide intended effect or metastases are found?
Assists clinicians to comprehensively assess the current status of cancer treatment and adjust treatment strategies accordingly
When surgical tumor biopsy is no longer available, how to assess the treatment effect?
Utilize the blood testing to monitor the effect of targeted therapy For lung cancer, breast cancer or colon cancer patients
When it comes to the Long-term personalized monitoring of cancer
Tailor-made monitoring analysis is designed on the unique molecular signature of each patient.
OncoDNA Personalized Cancer Genetic Testing Package
Solutions for OncoDNA New Generation Cancer Genetic Testing